XENE
Xenon Pharmaceuticals
$35.77
+$0.43 (+1.22%)Oct 26, 2026
Key metrics
The numbers that frame XENE today
- Market cap
- $3.46B
- ROIC
- -58.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $33.38
- 52wk High
- $72.66
Growth
Revenue and earnings trend for XENE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XENE
Is Xenon Pharmaceuticals a good buy?
No. Xenon Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Xenon Pharmaceuticals is selling at a very high price.
What is the market capitalization of XENE?
Xenon Pharmaceuticals's market capitalization is $3.46B.
What is the 52-week high for XENE stock?
The 52-week high for Xenon Pharmaceuticals is $72.66. The current close of $35.77 is 50.8% below that high.
What is the 52-week low for XENE stock?
The 52-week low for Xenon Pharmaceuticals is $33.38. The current close of $35.77 is 7.2% above that low.
Does XENE stock pay dividends?
Xenon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XENE?
Xenon Pharmaceuticals's Debt / Equity ratio is 0.01.